CTSO - CytoSorbents Corp. Analyst Forecast Prices
Cytosorbents (CTSO) develops automated blood filtration cartridges, where real-time digital flow control minimizes the risk of human error. The company's price history shows a current level of 34.71. Management is currently focused on implementing these systems in emergency medicine and obtaining US licenses to expand the therapeutic capabilities of its devices.
Analytical breakdowns for Cytosorbents (CTSO)
- market price and analyst price targets:
- market capitalization statistics:
- book capitalization information:
- issuer credit burden and liquidity indicators:
Aggregate Debt to Capital Cytosorbents|CTSO - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital cytosorbents.com|CTSO - Company Aggregate Debts|Debts to Book Value CytoSorbents Corp.|CTSO - Company Long-Term Debt|Company Short-Term Loans and Borrowings Cytosorbents|Quick Ratio cytosorbents.com
- net income and valuation ratios data:
CTSO - Company Net Income|Forward Earnings Cytosorbents|CTSO - P/E Multiple|Projected Price to Earnings Ratio cytosorbents.com|CTSO - Price/Earnings to Growth Multiple|EV/EBITDA Multiple CytoSorbents Corp.|CTSO - Operating profit before deduction of amortization|Earnings per share for the last four quarters Cytosorbents|CTSO - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months cytosorbents.com|CTSO - Earnings growth in current year|Expected earnings per share growth for next year Cytosorbents
General company analysis:CTSO - CytoSorbents Corp
FDA approval delays and the rapid depletion of liquidity at Cytosorbents (CTSO) create serious fundamental risks for the business's capitalization. Analyzing the analyst consensus chart for the stock, an investor can see the weighted average target price calculated via discounted cash flow (DCF), which allows for the real-time tracking of the asset's revaluation amid rising interest expenses and revenue uncertainty.
Competitors of Cytosorbents
Consensus Target dexcom.com DXCM|Penumbra - Consensus Target|Analyst Forecast Prices NOVT (Novanta Inc)|HAE - Price Target Chart|Analyst Median Target Inspire Medical Systems Inc INSP|PROCEPT BioRobotics (PRCT) - Price Target Chart|Average Forecast Price conmed.com (CNMD)|Consensus Target PLSE|INMD (InMode Ltd) - Analyst Forecast Prices|Analyst Consensus Forecast PMI|SRDX (Surmodics Inc.) - Fair Value Consensus|Analyst Consensus Forecast SENS (Senseonics Corp)|neuropace.com (NPCE) - Average Forecast Price|TCMD - Price Target Chart|Fair Value Consensus SNWV (SANUWAVE Health)|OM: Analyst Consensus Forecast|Electromed (ELMD) - Analyst Consensus Forecast|Price Target Chart LENSAR, Inc.|avitamedical.com - Forecast Levels Chart|Analyst Consensus Forecast PROF|BDMD - Average Forecast Price|EDAP TMS - Consensus Target|Analyst Consensus Forecast Apyx Medical Corp APYX|ICCM: Consensus Target|Pulmonx Corporation - Analyst Forecast Prices|TELA: Analyst Consensus Forecast|SRTS - Analyst Median Target|ZYXI (Zynex Inc) - Analyst Consensus Forecast|Consensus Target electroCore Medical (ECOR)|Consensus Target RBOT (Vicarious Surgical Inc.)|IINN (inspira-technologies.com) - Fair Value Consensus|Price Target Chart SeaStar Medical ICU|IRIX - Consensus Target|Intelligent Bio - Analyst Consensus Forecast|Average Forecast Price Beyond Air, Inc.|PFSA: Analyst Consensus Forecast|Broker Consensus Forecast SSKN|GCTK (GlucoTrack) - Analyst Consensus Forecast|NanoVibronix Inc. (NAOV) - Analyst Median Target|Analyst Consensus Forecast VERO|Consensus Target Nuwellis Corp NUWE|Analyst Consensus Forecast AEMD (Aethlon Medical)|Analyst Consensus Forecast Asensus Surgical Inc ASXC|AVGR - Price Target Chart|BSGM: Price Target Chart|CUTR (Cutera, Inc) - Consensus Target|Know Labs Corporation - Fair Value Consensus|NARI (Inari Medical, Inc.) - Analyst Consensus Forecast|Average Forecast Price nevro.com NVRO|Price Target Chart ReShape Lifesciences (RSLS)|Silk Road Medical, Inc. (SILK) - Analyst Target Range
